C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/37, 195/1.10
C12N 5/24 (2006.01) A61K 39/395 (2006.01) C07K 16/00 (2006.01) C12N 15/10 (2006.01) G01N 33/569 (2006.01)
Patent
CA 2033984
2033984 9100342 PCTABS00003 The process of the invention comprises the following steps: (a) isolation and preparation of cells exhibiting antigens, TH and B cell precursors from tumour-infiltrated people, those infected with procaryotic or eucaryotic exciters, especially viruses, or those with a hereditary disease; (b) activation of the TH and B cell precursors of (a) by bonding to the cells of (a) exhibiting antigens; (c) isolation and preparation of B cells from tumour-infiltrated people, those infected with procaryotic or eucaryotic exciters, especially viruses, those with a serious disease or healthy people; (d) activating the B cells of (c) by bonding to the antigen-activated TH and B cell precursors of (b), and (e) cloning the activated B cells of (d).
Pridun Nestor
Watzek Carl
Gowling Lafleur Henderson Llp
Idt Ag Fur In Vivo Diagnostik Und Therapie
Pridun Nestor
Watzek Carl
LandOfFree
Method for the production of human monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the production of human monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the production of human monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1376975